D-0076-2025 Class II Terminated
FDA drug recall D-0076-2025 was initiated by ACCORD HEALTHCARE, INC. on Nov 8, 2024 and is designated Class II. Reason for recall: Subpotent drug The recall status is terminated (terminated Sep 9, 2026).
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 11, 2024
- Initiation Date
- Nov 8, 2024
- Termination Date
- Sep 9, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17
Reason for Recall
Subpotent drug
Distribution Pattern
USA Nationwide
Code Information
Lot #: D2300191, Exp 12/31/2025